Patent · US Active

Anti-TNFα-antibodies and functional fragments thereof

US10774140B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Numab Therapeutics AG · CH

Inventors

Tea Gunde · Zürich, CH
Sebastian Meyer · Bielefeld, DE

Key dates

Filing date	Mar 16, 2017
Grant date	Sep 15, 2020
Priority date	—
Expiry date	Jun 12, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibody molecules and functional fragments thereof, capable of binding to tumor necrosis factor alpha (TNFα), to processes for their production, and to their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.